nad+ glp-1 V2 NAD GLP
Description
Find articles by Haq, N
These drugs show the potential to treat existing alcohol problems rather than avoiding problems before they start, so are inferior to upstream policies
This creates a first-mover incentive structure in the generic industry that turns patent challenge into a competitive sport
No PCAB accreditation stated
Do not stop abruptly without medical advicemay worsen hyperglycemia and complications (e.g., retinopathy, neuropathy)
